Bioscript Group
Julie Hamilton is currently the Senior Regulatory Business Manager at Bioscript. Prior to this role, Julie held the position of Senior Medical Writer at Quanticate and Research Scientist at The Royal (Dick) School of Veterinary Studies and Roslin Institute. Julie has a background in targeting epithelial to mesenchymal transition in oral squamous cell carcinoma. Julie also has experience as a Scientific Info and Comms Officer at the Institute of Genetics and Molecular Medicine and as a Project Manager at Innogen. With a PhD in Veterinary Oncology, an MSc in Equine Science, and a BSc in Life Sciences, Julie has a strong educational background to support their professional experience.
This person is not in the org chart
Bioscript Group
Established in 2005, Bioscript Group is formed from multiple, specialist businesses to support our global pharmaceutical clients; we draw on their multidisciplinary expertise to help navigate critical decisions at key points in the product lifecycle. Our scientific and strategic expertise help our clients make better decisions. We provide medical communication services, market access consulting and regulatory writing support with deep domain expertise to effectively navigate complex disease areas.